FDA agrees to take down Ivermectin posts in legal settlement with doctors
This report was created with support from enhanced software.
Media Landscape
This story is a Media Miss by the left as only 0% of the coverage is from left leaning media. Learn more about this data[LAUREN TAYLOR]
THE FDA AGREED TO REMOVE AND STOP REPOSTING SEVERAL SOCIAL MEDIA MESSAGES SUGGESTING IVERMECTIN, A DRUG SOME DOCTORS USED TO TREAT COVID, IS INTENDED FOR ANIMALS AND NOT HUMANS.
THE MOVE SETTLES A LAWSUIT FILED BY THREE DOCTORS WHO ACCUSED THE AGENCY OF HURTING THEIR MEDICAL PRACTICES. THE LAWSUIT TARGETED NOT ONLY THE FDA BUT THE DEPARTMENT OF HEALTH AND HUMAN SERVICES.
THE CASE WAS INITIALLY DISMISSED CITING THE FDA’S “SOVEREIGN IMMUNITY. HOWEVER, THE U.S. COURT OF APPEALS FOR THE FIFTH CIRCUIT OVERTURNED THE RULING. THE COURT SAID THE FDA’S ROLE IS NOT TO PROVIDE PERSONALIZED MEDICAL ADVICE.
AS A RESULT, THE FDA WILL NOW STOP PUBLISHING A CONSUMER UPDATE TITLED: “WHY YOU SHOULD NOT USE IVERMECTIN TO PREVENT COVID-19” AND REMOVE ALL RELATED SOCIAL MEDIA POSTS WITHIN 21 DAYS.
IVERMECTIN IS APPROVED FOR BOTH ANIMAL AND HUMAN USE, AND IS USED TO TREAT SOME PARASITIC INFECTIONS, HOWEVER, THE FDA STILL DOES NOT RECOMMEND IT FOR COVID TREATMENT, SAYING THERE IS DANGER OF EXCESSIVE DOSES.
IVERMECTIN ADVOCATES CELEBRATED THE RULING, AND INDEPENDENT PRESIDENTIAL CANDIDATE ROBERT F. KENNEDY JUNIOR CLAIMED THE FDA’S STANCE IS BIAS AGAINST “LOW-COST THERAPIES.”
THE FDA DECLINED TO COMMENT ON KENNEDY’S CLAIMS, BUT AGAIN SAID CLINICAL TRIAL DATA DOES NOT SUPPORT IVERMECTIN’S USE TO TREAT COVID.